Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells.
about
Stem cell donation--what advice can be given to the donor?H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cellsGeneration of induced pluripotent stem cells from CD34+ cells across blood drawn from multiple donors with non-integrating episomal vectorsHaematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.The aberrant asynchronous replication - characterizing lymphocytes of cancer patients - is erased following stem cell transplantationLower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.Granulocyte-colony stimulating factor for hematopoietic stem cell donation from healthy female donors during pregnancy and lactation: what do we know?Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors.Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors.Effects and safety of granulocyte colony-stimulating factor in healthy volunteersBiosimilar granulocyte-colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?Safeguarding the long-term health of hematopoietic stem cell donors: a continuous and evolving process to maintain donor safety and trust.Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone.Second cancers in patients with the Ewing sarcoma family of tumours.Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.The Vitamin E Analog Gamma-Tocotrienol (GT3) Suppresses Radiation-Induced Cytogenetic Damage.G-CSF in Healthy Allogeneic Stem Cell Donors.The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor.Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors.Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?Prevention of chemotherapy-induced neutropenia with pegfilgrastim: pharmacokinetics and patient outcomes.Hematopoietic stem cell donation.A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies.Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donors.Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association.Epigenetic analyses in blood cells of men suspected of prostate cancer predict the outcome of biopsy better than serum PSA levels.Administration of recombinant human granulocyte-colony-stimulating factor does not induce long-lasting detectable epigenetic alterations in healthy donors.Haematological malignancies in sibling and unrelated donors of allogeneic peripheral stem cells mobilised with G-CSF filgrastim: a transplant centre and Czech National Marrow Donors Registry experience.Volunteer unrelated donor experience after administration of filgrastim and apheresis for the collection of haemopoietic stem cells: the Australian perspective.Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history.Granulocyte-colony stimulating factor administration among hemoglobin S trait donors: A single center experience from the Eastern Mediterranean region.Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.The use of granulocyte colony-stimulating factor in volunteer blood and marrow registry donors.Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation.Attenuated DNA damage responses and increased apoptosis characterize human hematopoietic stem cells exposed to irradiation.Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation.Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study.Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study
P2860
Q24626108-3EABC956-EC13-4612-BC1C-234BD46FD820Q28475930-0554CE0C-FF8E-4B4E-983C-9D137A93FAFFQ28742368-7240FDFE-2CE9-44B2-B0DD-C3BCB86745A7Q33373051-3EEAE3B9-D311-43C3-991E-695C38F6B6D3Q33585868-BF3B4E98-259E-48AC-893D-883F9DE00800Q33718833-1CA8B26E-FF42-4BDE-94EF-C65F008790D1Q34320722-8A1082D0-29A9-4F92-8B49-B227D989BDC8Q34451574-A951B4FF-2F43-4C33-A129-435F25FE24B0Q35605853-DD7FEB90-7EF3-4A14-B503-52C78F6FBD0BQ35679682-C6B19919-4416-446B-8871-7592123B6579Q35835005-9D7D78A5-FC19-450E-B359-EF5BDB49EF50Q36162892-400B8B4B-7F69-4C77-AF74-E7BE9E995283Q36180365-90D097A8-A5A5-428F-8BC9-3F5857EEA0A1Q36711750-711AEEC4-CA6D-41D0-8278-7B845F65047DQ37052835-5E5ECD94-168B-4726-A716-E05CE8B2B6B5Q37139295-12B7EFB3-73AD-487E-A7E6-95A8CBA22500Q37180718-CD61FE8C-2BCF-420D-9A69-D437284EF62CQ37397999-8FFCBF0D-163A-460F-BE09-019BE267300FQ37552014-1FE1001F-31E4-422F-87CB-319461A5B2E5Q37996560-A6C239DE-34E1-4F00-B575-5AE5A4BE97BDQ38072290-563D3130-C018-4CD6-A0B9-3FA435B0832EQ38082689-7D0FEC1F-099B-4C2B-9E7D-7956D644B2D9Q38323097-91581E3B-445C-40E7-ADB1-11C9F515C8E2Q38517394-BAE16D69-4534-4B32-8297-3706B17C4361Q40398250-46ACAF52-8FC5-45F6-A5CB-A58FA82443B8Q42783305-9A54508B-9F47-4BE5-A5DF-4C74FB0C18ECQ42868154-859EEB40-7791-468E-9C0B-0CDACE7CCBC5Q44672321-3F1A8301-B30A-4637-A0AA-B60CA25FDF97Q44800806-4E8FDFC8-2BE0-4AFA-BD9D-C4ACC4F5A06DQ46661360-CF2E6EB4-AEDD-4267-B5D8-641DD24C72A0Q48123477-DFA6D5BF-0976-4DF5-9F79-CEEA49FB6CB7Q48140002-1EDC3EB1-5F4B-4F7C-82DB-641A7B4AFCEFQ50506365-1535A906-DF5D-4240-BBFF-5C78E1686931Q50714166-64147E40-FDBB-4AD9-BAE3-BD85C73401B1Q51004201-23611519-11CB-4173-8462-E0F6C258E24BQ52718694-19D6CE6B-93EF-40B8-9E17-A3E600C1A7DEQ53091868-E9EB8B09-CCB3-4E21-8072-E558D71F34E8Q53106181-DD2BDC43-AB3D-4DB3-82C7-D245EEF0BB82Q53127274-B98AF424-9C0B-4044-9339-72A752B3D74BQ56999553-9BEA7FFE-C319-46F9-9F78-13A1D62340E1
P2860
Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Granulocyte colony-stimulating ...... olunteer donors of stem cells.
@en
Granulocyte colony-stimulating ...... olunteer donors of stem cells.
@nl
type
label
Granulocyte colony-stimulating ...... olunteer donors of stem cells.
@en
Granulocyte colony-stimulating ...... olunteer donors of stem cells.
@nl
prefLabel
Granulocyte colony-stimulating ...... olunteer donors of stem cells.
@en
Granulocyte colony-stimulating ...... olunteer donors of stem cells.
@nl
P2093
P1476
Granulocyte colony-stimulating ...... olunteer donors of stem cells.
@en
P2093
Aliza Amiel
Arnon Nagler
Avital Korenstein-Ilan
Lydia Avivi
P304
P356
10.1016/J.EXPHEM.2003.09.007
P577
2004-01-01T00:00:00Z